The latest news on the fight to end viral hepatitis.
News
For media enquiries, contact: admin@endhep2030.org
Press Releases
Call for Proposals to Accelerate Action to Eliminate Viral Hepatitis
The Fund for Elimination of Viral Hepatitis (DBA "EndHep2030") announces a Call for Proposals for its inaugural set of grants (March 8, 2019. San Francisco, U.S.) EndHep2030 seeks partners with innovative approaches for accelerating the elimination of viral hepatitis. A complete list of eligibility requirements, selection criteria, and additional details regarding the application process are available at www.endhep2030.org/grants.
Dedicated fund is launched for global campaign to eliminate viral hepatitis.
The Fund for Elimination of Viral Hepatitis (DBA "EndHep2030") has been launched at the World Hepatitis Summit (November 1-3, 2017. Sao Paulo, Brazil). Conceived as a collaborative funding platform, EndHep2030 was a direct outcome of the International Roundtable Summit of Funding for Elimination of Viral Hepatitis (June 20-21, 2016. Hong Kong, China).
International Roundtable Summit on Funding for Elimination of Viral Hepatitis
In June 2016 ZeShan Foundation, in collaboration with the United States Centers for Disease Control and Prevention (US CDC) and the World Health Organization (WHO), convened a meeting designed to stimulate critical thinking and discussion around the establishment of an international funding mechanism to support the implementation of the Global Health Sector Strategy on Viral Hepatitis (“WHO Global Hepatitis Strategy”).
About EndHep2030
Viral Hepatitis Deaths Projected to Exceed HIV, TB, and Malaria Combined by 2040
Pledging conference But funding to help poor countries pay for the treatments and vaccines to cure and eliminate this debilitating disease remains elusive. To address this issue, the Hepatitis Fund and CHAI will hold the first-ever pledging conference in Geneva next week. The conference hopes to raise $150 million to support countries that are committed[…..]
Global Priority Statement: Integrate Hepatitis B Responses into Harm Reduction
The Viral Hepatitis Pre-Conference, as part of the Harm Reduction International 2023 Conference #HR23 is calling for action to integrate Hepatitis B responses into harm reduction. Join us in ensuring that every person who inject drug has the right to be protected from Hepatitis B infection and has access to the care they need.
Hepatitis Fund aims to accelerate viral hepatitis elimination
The Lancet - Hepatitis Fund aims to accelerate viral hepatitis elimination
Handling of Hepatitis Not Integrated
Handling of Hepatitis Not Integrated – FULL ARTICLE HERE Hepatitis is still claiming many lives globally, and limited access to examination and treatment services remains a significant obstacle to controlling the disease. In Indonesia, collaborations between different parties have led to the implementation of hepatitis prevention programmes. However, THF’s Director of Programme and Partnerships Capucine Pénicaud ,[…..]
EndHep2030 relocates to Geneva
Funding the elimination of viral hepatitis: donors needed
Lancet, December 2017
Fondo global para financiar la eliminación de la hepatitis viral
Hepatitis2000, February 2019
Global fund for hepatitis prepares for rollout
Devex, February 2019
In the News
THF at the Global Hepatitis Summit 2023
From 25 to 28 April 2023, we will be in Paris at the Global Hepatitis Summit 2023 (the 18th International Symposium on Viral Hepatitis and Liver Disease – ISVHLD). On Thursday, 27 April (8.30 – 10.30), our Senior Grant Manager, Maria Carolina Salazar, will join the WHO Symposium “Viral hepatitis elimination – What’s new, what’s[…..]
Statement: The Hepatitis Fund (THF) today warmly welcomed the announcement by Unitaid of US$ 31 million to fund three new consortia charged with working to more effective prevention of hepatitis C (HCV) infection amongst people who inject drugs and prisoners.
Nearly 40 per cent (six million) of people who inject drugs globally are currently living with hepatitis C. But less than 10 per cent of those who need it have accessed treatment. “We need creative programmes that are capable of reaching the most vulnerable with those drugs we know can cure the disease,” said Helen[…..]
HR23 pre-conference on viral hepatitis and harm reduction
On 15 April, our Programme and Partnership Director, Capucine Penicaud, will be in Melbourne for the HR23 pre-conference on viral hepatitis and harm reduction. He will join a panel of experts, including representatives from CHAI, INPUD, The Global Fund to fight AIDS, Tuberculosis and Malaria and Harm Reduction International, to discuss the financial landscape around[…..]
New partnership with Muslim World League
We’re pleased to share that we started a new partnership with the Muslim World League (WML). WML is supporting our efforts as part of its involvement in global health. WML is an engaged supporter of health-related initiatives and, in recent years, implemented various programmes that provided healthcare to more than one million people. We believe[…..]
The latest news in viral hepatitis elimination.
The Hepatitis Fund first Activity Report has been released on World Hepatitis Day 2021. Find it here. How can the world end viral hepatitis by 2030? 5 experts explain. Read Manal El-Sayed blog post contribution for WHD 2021 here. Financing the elimination of viral hepatitis. Watch this World Economic Forum and Hepatitis Fund roundtable, in cooperation[…..]
Pakistan announces a new ambitious plan to eliminate viral hepatitis by 2030
On World Hepatitis Day, the Government of Pakistan announced a new ambitious plan by the Prime Minister to eliminate viral hepatitis by 2030. The plan was unveiled by Dr Zafar Mirza, Special Assistant to the Prime Minister, and aims to scale up hepatitis prevention, testing and treatment services by screening up to 140 million people in[…..]